ACURATE neo2 is the next iteration of the ACURATE neo valve. It features Active PVseal™ technology and an extended sealing skirt to cover the full waist of the stent, radiopaque positioning marker designed to give a clear visual reference for easy and accurate positioning, and extra wide stabilization arches to facilitate coronary access. ACURATE neo2 received CE Mark in April 2020.
History of ACURATE
The ACURATE valve has been implanted in more than 35,000 patients across more than 20 countries globally. More than 2,400 patients have been included in past clinical research.
